Intract Pharma’s portfolio of oral delivery systems includes controlled-release technologies targeting specific regions of the large and small intestine, and a technology for enabling oral delivery of biotherapeutics previously only suitable for injection. It has also developed proprietary GI models.
Intract Pharma Ltd
Phone / ContactT: +44 20 7753 5908
Authors and Contacts
W3 Total Cache is currently running in Pro version Development mode.